Julie Rubinstein

Julie Rubinstein serves as President and Chief Operating Officer at Adaptive Biotechnologies Corp.. Adaptive Biotechnologies Corp. operates in the biotechnology sector with approximately 660.0 employees. The company is headquartered in New York, New York. Adaptive Biotechnologies Corp. generates annual revenue of 180000000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Outlook Amazon AWS Pardot VueJS Pantheon Atlassian Cloud Tableau OneTrust Greenhouse.io Salesforce Mobile Friendly Nginx Google Tag Manager Varnish Adobe Media Optimizer New Relic Cedexis Radar reCAPTCHA Vimeo Bootstrap Framework Wistia Google Analytics WordPress.org Remote AI

biotechnology research diagnostic therapeutics healthcare life sciences biotechnology: biological products (no diagnostic substances) health care immune medicine mrd testing clonoseq adaptive immune system t-cell receptor sequencing antibody therapeutics cancer diagnostics biopharma solutions drug discovery target discovery clinical diagnostics biopharma services minimal residual disease tcr therapeutics adaptive immunosequencing personalized medicine hematologic malignancies cancer therapeutics precision medicine clinical trials patient monitoring immune response genomics molecular diagnostics data-driven medicine tcr antigen mapping clinical portfolio fda-cleared tests advanced genetic testing diagnostic platforms translational medicine clinical workflow integration healthcare innovation biopharmaceutical development immunotherapy therapeutic antibodies cancer treatment autoimmune disease treatment infectious disease diagnostics regulatory compliance laboratory services healthcare data analytics longitudinal monitoring patient outcomes emerging technologies adaptive science innovative therapies real-world evidence immunosequencing disease diagnosis disease treatment mrd assessment t-cell receptor b-cell receptor next-generation sequencing immune profiling oncology autoimmune diseases infectious diseases neurodegenerative disorders healthcare providers pharmaceutical partnerships life sciences research genetic language innovative technology patient care therapeutic targets advanced diagnostics healthcare accessibility ai-driven insights immune-mediated diseases transformative therapies clonoseq assay t-detect pharma services immune receptor data disease monitoring early detection treatment personalization corporate social responsibility health wellness & fitness hospital & health care

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

CH

Chris Harano President and CEO at Advanced BioCatalytics

IC

Ismail Ceylan Président et CEO at Advanced BioDesign

How can I contact Julie Rubinstein?

Julie Rubinstein's verified email address is available on MessageCEO. They currently work at Adaptive Biotechnologies Corp.. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Julie Rubinstein lead?

Julie Rubinstein is President and Chief Operating Officer at Adaptive Biotechnologies Corp., a company in the biotechnology sector with 660.0 employees. The company is based in New York, New York.

What industry is Julie Rubinstein in?

Julie Rubinstein works in the biotechnology industry as President and Chief Operating Officer at Adaptive Biotechnologies Corp.. MessageCEO provides verified contact information for executives across all major industries.

Is Julie Rubinstein's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Julie Rubinstein's profile is kept up-to-date with the latest available information.

Last updated: April 8, 2026